JP2023533289A5 - - Google Patents
Info
- Publication number
- JP2023533289A5 JP2023533289A5 JP2023501090A JP2023501090A JP2023533289A5 JP 2023533289 A5 JP2023533289 A5 JP 2023533289A5 JP 2023501090 A JP2023501090 A JP 2023501090A JP 2023501090 A JP2023501090 A JP 2023501090A JP 2023533289 A5 JP2023533289 A5 JP 2023533289A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- thc
- acceptable salt
- carbonic anhydrase
- anhydrase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020902368 | 2020-07-09 | ||
| AU2020902368A AU2020902368A0 (en) | 2020-07-09 | A method of treatment | |
| PCT/AU2021/050734 WO2022006636A1 (en) | 2020-07-09 | 2021-07-09 | Compositions and methods for the treatment of obstructive sleep apnoea (osa) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533289A JP2023533289A (ja) | 2023-08-02 |
| JP2023533289A5 true JP2023533289A5 (https=) | 2024-07-09 |
| JP7796718B2 JP7796718B2 (ja) | 2026-01-09 |
Family
ID=79553355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501090A Active JP7796718B2 (ja) | 2020-07-09 | 2021-07-09 | 閉塞性睡眠時無呼吸（ｏｓａ）の治療のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230310364A1 (https=) |
| EP (1) | EP4178568A4 (https=) |
| JP (1) | JP7796718B2 (https=) |
| AU (1) | AU2021306424A1 (https=) |
| CA (1) | CA3182528A1 (https=) |
| CO (1) | CO2023000118A2 (https=) |
| IL (1) | IL299212A (https=) |
| WO (1) | WO2022006636A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025520386A (ja) * | 2022-06-21 | 2025-07-03 | アプニメッド，インコーポレイテッド（デラウェア） | カンナビノイドおよびカルボニックアンヒドラーゼ阻害剤の組合せを用いた睡眠時無呼吸を治療する方法 |
| EP4626410A1 (en) * | 2022-11-29 | 2025-10-08 | Incannex Healthcare Limited | A method of treating obstructive sleep apnoea (osa) |
| WO2025107039A1 (en) * | 2023-11-23 | 2025-05-30 | Incannex Healthcare Limited | Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule |
| WO2025191322A1 (en) * | 2024-03-11 | 2025-09-18 | Mousavi Mirzaei Seyed Mohammad | Therapeutic composition for improving symptoms of obstructive sleep apnea |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3090743A1 (en) * | 2008-01-09 | 2016-11-09 | Charleston Laboratories, Inc. | Pharmaceutical compositions for treating headache and eliminating nausea |
| WO2019071302A1 (en) * | 2017-10-09 | 2019-04-18 | The University Of Sydney | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES |
| CA3126772A1 (en) * | 2018-01-29 | 2019-08-01 | Evero | Compositions and methods for treating obstructive sleep apnea |
| WO2019180706A1 (en) * | 2018-03-19 | 2019-09-26 | Bol Pharma Ltd. | Methods and compositions for treating epilepsy and associated disorders |
| US20240189328A1 (en) * | 2021-04-16 | 2024-06-13 | Apnimed, Inc. (Delaware) | Combination of norepinephrine reuptake inhibitor and a cannabinoid for use in treating sleep apnea |
-
2021
- 2021-07-09 WO PCT/AU2021/050734 patent/WO2022006636A1/en not_active Ceased
- 2021-07-09 US US18/000,880 patent/US20230310364A1/en active Pending
- 2021-07-09 EP EP21837113.6A patent/EP4178568A4/en active Pending
- 2021-07-09 JP JP2023501090A patent/JP7796718B2/ja active Active
- 2021-07-09 IL IL299212A patent/IL299212A/en unknown
- 2021-07-09 CA CA3182528A patent/CA3182528A1/en active Pending
- 2021-07-09 AU AU2021306424A patent/AU2021306424A1/en active Pending
-
2023
- 2023-01-06 CO CONC2023/0000118A patent/CO2023000118A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533289A5 (https=) | ||
| JP2025092508A5 (https=) | ||
| JP2010518122A5 (https=) | ||
| CY1119001T1 (el) | Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για ανευ νοηματος καταστολη και τη θεραπεια ασθενειας | |
| AU4944799A (en) | A pharmaceutical combination comprising a cox-2 inhibitor and a inos inhibitor | |
| SI2760821T1 (en) | A salt salt of an anti-inflammatory substituted cyclobutenedione compound | |
| JP2021080296A5 (https=) | ||
| RU2012142811A (ru) | Фармацевтические композиции и пероральные дозированные формы пролекарства леводопы и способы применения | |
| JP2022163049A5 (https=) | ||
| JP2009526865A5 (https=) | ||
| EA201000120A1 (ru) | Фармацевтические композиции, содержащие холиновые соли янтарной кислоты, для интраназального введения | |
| ES2489265T3 (es) | Asociación de inhibidores de la HMG-CoA reductasa atorvastatina o simvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast para el tratamiento de enfermedades pulmonares inflamatorias | |
| JP2022511788A5 (https=) | ||
| JP2009518415A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| WO2019178516A1 (en) | Methods and compositions to treat enteropathic arthritis | |
| JP2023506196A (ja) | 化合物及びα１－アンチトリプシン欠損症の治療のためのそれらの使用 | |
| JP2005519936A5 (https=) | ||
| JP2023517919A5 (https=) | ||
| US20180125792A1 (en) | Non-steroidal anti-inflammatory drugs for cough | |
| CA2964684A1 (en) | Composition for the treatment of conditions involving muscular pain | |
| JP2008088189A5 (https=) | ||
| JP2013518061A5 (https=) | ||
| JP2008115167A (ja) | トラネキサム酸を含有する気道杯細胞過形成抑制剤 | |
| MX2025007158A (es) | Inhibidores de gmp?amp sintasa ciclica y sus usos |